By Conjoint Professor Dedee Frances Murrell

Journal articles

Amsalu A; Haidari H; Mirco B; Rudolph-Stringer V; Walter S; Antipov A; Murrell DF; Kopecki Z, 2026, 'Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients', Orphanet Journal of Rare Diseases, 21, http://dx.doi.org/10.1186/s13023-026-04295-5

Akbarialiabad H; Safaee E; Letafati M; Gong J; Leachman SA; Grada A; Pasdar A; Janatifar M; Shakil F; Bunick CG; Murrell DF; Tarbox M; West C; Haghighi A, 2026, 'Generative AI empowered digital twins for advancing precision medicine', Discover Artificial Intelligence, 6, http://dx.doi.org/10.1007/s44163-026-01034-4

Joly P; Murrell DF; Aoyama Y; Caux F; De D; Flouri M; Goebeler M; Ji C; Kiritsi D; Pan M; Patsatsi A; Schmidt E; Vassileva S; Vandersarren L; Stoykov I; Verheesen P; Werth VP; Hall RP; Murrell D; Kern J; Vassileva S; Kantardjiev V; Gospodinov D; Li H; Li W; Pan M; Chen Y; Ji C; Zhang S; Fang S; Perrot J-L; Templier I; Caux F; Joly P; Buchukuri I; Galdava G; Kobakhidze J; Hertl M; Kiritsi D; Pinter A; Hahn M; Goebeler M; Gerdes S; Günther C; Chasapi V; Ioannides D; Papadavid E; Papakonstantis M; Patsatsi A; Stratigos A; Bata-Csörgő Z; Remenyik É; De D; Shah B; Mukhi J; Madan A; De Simone C; Didona B; Parodi A; Caproni M; Micali G; Cinotti E; Tanaka A; Aoyama Y; Osada A; Ujiie H; Tsuruta D; Ishii N; Kambayashi Y; Reich A; Placzek K; Szepietowski J; Zebrowska A; Baican AL; Solovăstru LG; Khotko A; Skrek S; Temnikov V; Kokhan M; Sokolovskiy E; Gajinov Z; Tiodorovic D; Barbarin JF; Galy J-MM; Bueno DM; Kutlubay Z; Polion N; Reznichenko N; Lytvynenko B; Chaplyk-Chyzho I; Aleksandruk O; Chua SL; Shipley DV; Carrasco D; Graham L; Colton A; Sinha A; Mangold A; Marinkovich MP; Hall R; Hsu S; Hurley M; Waibel J, 2026, 'Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial', British Journal of Dermatology, pp. ljag199, http://dx.doi.org/10.1093/bjd/ljag199

Cascio Ingurgio R; Alfano A; Syed A; Gargiulo L; Narcisi A; Costanzo A; Murrell DF, 2026, 'Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study', Journal of Dermatology, 53, pp. 1353 - 1357, http://dx.doi.org/10.1111/1346-8138.70389

Murrell DF; Boucher D; Daneshpazhooh M; Mahmoudi H; Kianfar N; Dasdar S; Yale M; Wilson A; Bilgic A; Uzun S; Chandran NS; Patsatsi A; Drenovska K; Vassileva S; Caux F; Culton DA; Hertl M; Lim YL; Marinović B; Marzano AV; Payne AS; Schmidt E; Sprecher E; Van Beek N; Yamagami J; Antiga E; Bagci IS; Borradori L; Caproni M; Corrà A; De D; Dunn P; Feliciani C; Fivenson DP; Günther C; Handa S; Horvath B; Ioannides D; Kasperkiewicz M; Kowalewski C; Lehman JS; Lipman RE; Mascaró JM; Meijer JM; Mimouni D; Schultz B; Skiljevic D; Strong B; Tomayko M; Vestergaard C; Wozniak K; Yayli S; Joly P; Werth VP, 2026, 'International development of Investigator Global Assessment scores for pemphigus', Journal of the European Academy of Dermatology and Venereology, 40, pp. e807 - e812, http://dx.doi.org/10.1111/jdv.70430

Hwang S; Stark M; Taylor SC; Rodrigues M; Alexis A; Murrell DF, 2026, 'Severity outcome measures in patients with skin of color: Gaps in current scoring systems and opportunities for improvement', Jaad Reviews, 9, pp. 73 - 84, http://dx.doi.org/10.1016/j.jdrv.2026.05.005

Pan JT; Daniel BS; Tan B; Lim BXH; Murrell DF; Watson SL; Lim CHL, 2026, 'Highlighting Ophthalmic Adverse Effects Associated with Isotretinoin', Life, 16, pp. 1441, http://dx.doi.org/10.3390/life16091441

Silverberg JI; Rosmarin D; Bieber T; Chovatiya R; Gooderham M; Gkalpakiotis S; Reich A; Murrell DF; Skibinska J; Sadick N; Blajić I; Tsianakas A; Fernandez-Penas P; Kern JS; Montero-Vílchez T; Popov TA; Kurian A; Sauder MB; Laquer VT; Chaudhry S; Lee ZH; Hannaway M; Yu D; Liu Y; Fanton C; Lu H; Kotzin B; Tagliaferri M; Zalevsky J; Warren RB, 2026, 'Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study', Lancet London England, 408, pp. 833 - 846, http://dx.doi.org/10.1016/S0140-6736(26)01143-8

Walter S; Martin LK; Murrell DF, 2026, 'Gender balance at international medical congresses: The EADV congress example, 2015–2023', Journal of the European Academy of Dermatology and Venereology, 40, pp. e709 - e711, http://dx.doi.org/10.1111/jdv.70386

Tan B; Yang A; Murrell DF, 2026, 'Repurposing therapies in junctional epidermolysis bullosa: Oral ivermectin therapy associated with improved wound healing and reduced pruritus', Jaad Case Reports, 74, pp. 218 - 220, http://dx.doi.org/10.1016/j.jdcr.2026.06.019

Silverberg JI; Beck LA; Gooderham M; Murrell DF; Wiseman MC; Sørensen L; Jönsson PG; Stein-Gold L, 2026, 'Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial', British Journal of Dermatology, pp. ljag296, http://dx.doi.org/10.1093/bjd/ljag296

Pathak GN; Syed A; Pathak SS; Tan B; Murrell DF, 2026, 'Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort.', Clin Exp Dermatol, http://dx.doi.org/10.1093/ced/llag312

Gold LS; Armstrong AW; Soung J; Vender RB; Cantero ÁG; Hoffmann M; Guenthner ST; Hong HC-H; Murrell DF; Song EJ; Kircik L; Augustin M; Sauder M; Gerdes S; Reyes-Servin O; Edem BE; Campbell J; Cresswell K; Kephart L; Li S; Yang Y-W; Bissonnette R, 2026, 'Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials', British Journal of Dermatology, pp. ljag264, http://dx.doi.org/10.1093/bjd/ljag264

Nanda A; Tedbirt B; Bodemer C; Bolling MC; El Hachem M; Nikolić M; Benton E; Caproni M; De D; Didona D; Drenovska K; Goebeler M; Hertl M; Horváth B; Kasperkiewicz M; Kiritsi D; Larralde M; Marzano AV; Meijer J; Murrell DF; Powell J; Sprecher E; Chandran NS; Tomayko MM; Uzun S; van Beek N; Ott H; Patsatsi A; Torrelo A; Welfringer-Morin A; Schmidt E; Joly P, 2026, 'European S2k guidelines on management of autoimmune blistering diseases in children and adolescents', Journal of the European Academy of Dermatology and Venereology, 40, pp. 1137 - 1161, http://dx.doi.org/10.1111/jdv.70308

Syed A; Leung HFA; Tan B; Melbourne W; Murrell DF, 2026, 'Successful treatment of chemotherapy-induced linear bullous lichen planus with dupilumab', Jaad Case Reports, 73, pp. 177 - 181, http://dx.doi.org/10.1016/j.jdcr.2026.05.005

Syed A; Khan MT; Murrell DF, 2026, 'Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex', Australasian Journal of Dermatology, 67, pp. e255 - e256, http://dx.doi.org/10.1111/ajd.70086

Pathak GN; Tan B; Syed A; Murrell DF, 2026, 'Immunomodulators and Antineoplastics Are Reported in Drug-Associated Epidermolysis Bullosa Acquisita Flares: A Retrospective Analysis of 58 Reported Cases Utilizing Multiple International Pharmacovigilance Databases', International Journal of Dermatology, 65, pp. 1114 - 1116, http://dx.doi.org/10.1111/ijd.70218

Murrell DF; Yamagami J, 2026, 'The plot thickens in pemphigus: New therapeutic targets from state-of-the-art ex vivo assays', Journal of Investigative Dermatology, 146, pp. 876 - 878, http://dx.doi.org/10.1016/j.jid.2026.01.001

Heyworth A; Stark M; Murrell D, 2026, 'Bewertungssysteme für das Schleimhautpemphigoid – eine Literaturübersicht', Skin, pp. 32 - 33, http://dx.doi.org/10.61783/oegdv10905

Stark M; Rivero ADL; Murrell DF, 2026, 'Photoallergic drug eruption secondary to oral terbinafine prescribed for management of tinea incognita', Skin, pp. 20 - 21, http://dx.doi.org/10.61783/oegdv10803

Dulai AS; Murase EM; Avallone G; Ferrucci SM; Marzano AV; Ribero S; Ardern-Jones M; Ko E; Flohr C; Leshem YA; Deleuran M; Vestergaard C; Hijnen DJ; Bras J; Elman SA; Pruneddu S; Butler D; Chovatiya R; Girolomoni G; Golant AK; Kamsteeg M; Luna PC; Murrell DF; Stark M; Torres T; Yildrim EA; Aractingi S; Bangert C; Batchelor R; Chen KY; Irvine AD; Lullo JJ; Martin LK; Maul JT; Pérez B; Rosmarin D; Sansom JE; Schultz B; Shipman A; Silverberg NB; Szalai Z; Fodor A; Tanaka AA; Viola K; Sivamani RK; Murase JE, 2026, 'International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes', Journal of the American Academy of Dermatology, 94, pp. 936 - 940, http://dx.doi.org/10.1016/j.jaad.2025.10.123

Syed A; Sarsam S; Murrell DF, 2026, 'Dual control of chronic plaque psoriasis and pouchitis with tildrakizumab', Clinical and Experimental Dermatology, 51, pp. 313 - 314, http://dx.doi.org/10.1093/ced/llaf468

Tseng H; Frew JW; Murrell DF, 2026, 'Viral infections as triggers in autoimmune blistering diseases: A systematic review of associations and mechanisms', Jaad International, 24, pp. 132 - 133, http://dx.doi.org/10.1016/j.jdin.2025.09.007

Zambruno G; Samela T; Diociaiuti A; Salamon G; Strobl S; Pilo C; Abeni D; Linertová R; Murrell DF; Hachem MEL, 2026, 'A Cross-sectional Study on Quality of Life in EB: Validation of the Italian QOLEB and Assessment in Italian Patients', Acta Dermato Venereologica, 106, http://dx.doi.org/10.2340/actadv.v106.adv-2026-0543

Vu JT; Ahuja R; Murrell DF, 2026, 'Balancing feasibility and sensitivity: Investigator global assessments for lupus and dermatomyositis', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70612

Has C; di Calabria VR; Caproni M; Didona B; Fischer J; Gostynski A; Javid AH; Hannula-Jouppi K; Hofmann J; Maione V; Salavastru C; Zanghi S; Bauer JW; Giehl K; Gruber R; Harjama L; Marinovic B; Moosbrugger-Martinz V; Medvecz M; Müller S; Murrell D; Navarini A; Morice-Picard F; Schmuth M; Severino-Freire M; Tournier C; Dodiuk-Gad R; Bodemer C; Mazereeuw-Hautier J, 2026, 'Consensus Recommendations for Management of Darier Disease: A Practical Approach', Dermatology and Therapy, http://dx.doi.org/10.1007/s13555-026-01838-3

Cascio Ingurgio R; Alfano A; Costanzo A; Cronk JS; Cummins R; Daniel BS; Koszegi BJ; Martin LK; Mendoza CG; Ramirez-Quizon M; Rhodes LM; Rishel HI; Rubin AI; Satgé F; Venugopal S; Wilson A; Murrell DF, 2026, 'Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70524

Labbouz S; Hovnanian A; Xiong G; Murrell DF; Mueller SM; Ezzedine K; Mohandesi NA; Aldhaheri AS; Asayag N; Baselga E; Nadler C; Choate K; Chu CY; Edminister JR; Guenova E; Gönülal M; Gostynski A; Gupta A; Gupta LK; Mazereeuw-Hautier J; Hoetzenecker W; Itin P; Jankowski M; Kubo A; Lee HY; Lehman JS; Lepekhova A; Medvecz M; Mellerio JE; Moosbrugger-Martinz V; Paller AS; Plázár D; Queiróz AJR; Riera-Monroig J; Rosa R; Schmuth M; Freire MS; Shabat I; Shapiro J; Simpson CL; Soto-García D; Stratigos AJ; Tadini GA; Takeichi T; Verma KK; Wikström JD; Zink A; Ziv M; Navarini A; Dodiuk-Gad RP, 2026, 'Darier disease—A review highlighting new insights from the Darier Disease International Task Force', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70483

Nayee S; Harte M; Ingen-Housz-Oro S; Ameri M; Walsh S; Joly P; Ardern-Jones M; Brailo V; Brueggen MC; Bunker C; Carey B; Carrozzo M; Chua SL; Creamer D; Culton D; Delli K; Diniz-Freitas M; Dodiuk-Gad R; Dridi SM; Ejeil AL; French L; Gaspar K; Higham J; Horvarth B; Hullah E; Jurge S; McMillan R; McParland H; Murrell D; Ormond M; Poveda-Gallego A; Samimi M; Schmidt E; Shephard M; Sollecito T; Taylor J; Uzun S; Valiukeviciene S; Willis A; Setterfield J, 2026, 'Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70578

Sprecher E; Torres-Pradilla M; Fernandez MF; Bodemer C; Bruckner AL; de Macedo Barbosa SM; Diociaiuti A; Martinez AE; Palisson F; Nikolić M; Vicente A; de Lucas R; Temin NT; Löwe S; Kern JS; Murrell DF, 2026, 'Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa', Pediatric Dermatology, http://dx.doi.org/10.1111/pde.70224

Murrell DF; Bodemer C; Bruckner AL; Cunningham T; Davis C; Fernández MF; Kiritsi D; Maher L; Sprecher E; Torres-Pradilla M; Kern JS, 2026, 'Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authors', British Journal of Dermatology, 194, pp. 175 - 177, http://dx.doi.org/10.1093/bjd/ljaf365

Korte EWH; Hiel MAJ; Bolling MC; Dunn P; Murrell DF; Werth VP; Yale M; Spuls PI; Meijer JM; Horváth B, 2026, 'Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey', British Journal of Dermatology, 194, pp. 165 - 167, http://dx.doi.org/10.1093/bjd/ljaf366

Yang A; Tan B; Murrell DF, 2026, 'Neutrophilic Dermatosis and Pyoderma Gangrenosum: A Not-So-Sweet Adverse Reaction to Pembrolizumab', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.70133

Chernyshov PV; Finlay AY; Patsatsi A; Marinović B; Salavastru C; Murrell DF; Tomas-Aragones L; Poot F; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Koumaki D; Suru A; Abeni D; Salek SS; Gregoriou S; Antiga E; Werth VP; Augustin M; Szepietowski JC; Schmidt E, 2026, 'Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases', International Journal of Dermatology, 65, pp. 18 - 27, http://dx.doi.org/10.1111/ijd.17964

Ahuja R; Hong S; Murrell DF, 2026, 'Reassessing Remission in Pemphigus Vulgaris: Beyond Complete Remission Towards Meaningful Disease Control', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.70652

Zhou AE; Sloan B; Murrell DF; Grant-Kels JM, 2026, 'Response to Hassan and Paas, “Curbing paper mills in departments and journals”', Journal of the American Academy of Dermatology, 94, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2025.09.071

Cascio Ingurgio R; Alfano A; Costanzo A; Cronk JS; Cummins R; Daniel BS; Koszegi BJ; Martin LK; Mendoza CG; Ramirez-Quizon M; Rhodes LM; Rishel HI; Rubin AI; Satgé F; Venugopal S; Wilson A; Murrell DF, 2026, 'Response to methodological concerns in cumulative isotretinoin dose trials', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70719

Akbarialiabad H; Parvar SY; Grada A; Bunick CG; Shimada K; Melin MM; Taghrir MH; Crucian B; Costes SV; Sanders LM; Paller A; Leachman SA; Alavi A; Lehman JS; El-Hamdi NS; Christiansen R; Tarbox M; Grant-Kels JM; Mostaghimi A; West C; Goldust M; Keshtmand G; Mesinkovska NA; Sadeghian N; Beheshti A; Murrell DF, 2026, 'Space-related dermatoses', Clinics in Dermatology, 44, pp. 87 - 99, http://dx.doi.org/10.1016/j.clindermatol.2025.10.006

Patzelt S; Engin RM; Drenovska K; Kiehne C; Probst C; Komorowski L; Mindorf S; Daneshpazhooh M; Kim SC; Farnetani F; Vaschieri C; Rao R; Marzano AV; Dmochowski M; Patsatsi A; Murrell D; Kern JS; Karakök Kışla H; Sprecher E; De D; Di Zenzo G; Borradori L; Jedlickova H; Zhu X; Schmidt E; Goletz S, 2026, 'Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study', British Journal of Dermatology, 194, pp. 163 - 165, http://dx.doi.org/10.1093/bjd/ljaf385

Andreou S; Sarsam S; Murrell DF, 2026, 'Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa', Expert Review of Clinical Pharmacology, 19, pp. 269 - 273, http://dx.doi.org/10.1080/17512433.2026.2641138

Pathak G; Tan B; Syed A; Murrell D, 2026, '75974 Triggers for epidermolysis bullosa acquisita flares: A multi-database retrospective pharmacovigilance study', Journal of the American Academy of Dermatology, 95, pp. ab462, http://dx.doi.org/10.1016/j.jaad.2026.04.1837

Pathak G; Syed A; Pathak S; Tan B; Murrell D, 2026, '75990 Risk of malignancies in patients with bullous pemphigoid; a case-control study', Journal of the American Academy of Dermatology, 95, pp. ab390, http://dx.doi.org/10.1016/j.jaad.2026.04.1555

Reich A; Murrell D; Legat FJ; Tauber M; Wollenberg A; Abramovits W; Ulianov L; Ryzhkova A; Cheong SY; Piketty C, 2026, '76688 Long-term efficacy and safety of nemolizumab in adolescents with moderate-to-severe atopic dermatitis: Post hoc analyses from ARCADIA LTE 2-year cut-off', Journal of the American Academy of Dermatology, 95, pp. ab287, http://dx.doi.org/10.1016/j.jaad.2026.04.1158

Syed A; Tan B; Murrell DF, 2026, 'Glossed over: the increasing importance of ultraviolet-cured gel nail polish in allergic contact dermatitis', International Journal of Women's Dermatology, 12, pp. e267, http://dx.doi.org/10.1097/jw9.0000000000000267

Tseng H; Frew JW; Murrell DF, 2026, 'Rituximab for autoimmune blistering diseases in pregnancy and children: a clinical review', International Journal of Women's Dermatology, 12, pp. e270, http://dx.doi.org/10.1097/jw9.0000000000000270

Baird J; Murrell D, 2025, 'P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases', British Journal of Dermatology, 193, http://dx.doi.org/10.1093/bjd/ljaf465.030

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Author Correction: Bullous pemphigoid (Nature Reviews Disease Primers, (2025), 11, 1, (12), 10.1038/s41572-025-00595-5)', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00605-6

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Bullous pemphigoid', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00595-5

Cascio Ingurgio R; Alfano A; Matteodo E; Stark M; Valenti M; Narcisi A; Costanzo A; Murrell DF, 2025, 'Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation', Australasian Journal of Dermatology, 66, pp. 468 - 474, http://dx.doi.org/10.1111/ajd.14592

Gooderham M; Torres T; Imafuku S; Rademaker M; Prajapati VH; Tsianakas A; Murrell DF; Owczarek W; Han Y; Lee WJ; Levy G; Ibrahim N; Moreira A; Shams K, 2025, 'Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: Results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)', British Journal of Dermatology, 193, pp. 1101 - 1111, http://dx.doi.org/10.1093/bjd/ljaf236

Back to profile page